Group One Trading, L.P. Lantheus Holdings, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$51.07 - $68.26 $171,084 - $228,671	3,350 New	3,350 $208,000
Q3 2023 Nov 09, 2023	SELL	$60.27 - $90.75 $680,689 - $1.02 Million	-11,294 Reduced 55.51%	9,052 $628,000
Q2 2023 Aug 09, 2023	BUY	$82.41 - $99.65 $1.68 Million - $2.03 Million	20,346 New	20,346 $1.71 Million
Q4 2022 Feb 09, 2023	BUY	$48.76 - $77.67 $327,667 - $521,942	6,720 New	6,720 $342,000
Q2 2022 Aug 11, 2022	BUY	$55.54 - $72.65 $160,066 - $209,377	2,882 New	2,882 $190,000
Q3 2021 Nov 12, 2021	SELL	$24.23 - $28.59 $350,729 - $413,840	-14,475 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$19.51 - $27.64 $262,331 - $371,647	13,446 Added 1306.71%	14,475 $400,000
Q1 2021 May 12, 2021	SELL	$13.77 - $21.66 $17,859 - $28,093	-1,297 Reduced 55.76%	1,029 $22,000
Q3 2020 Nov 12, 2020	SELL	$11.98 - $16.34 $64,895 - $88,513	-5,417 Reduced 69.96%	2,326 $29,000
Q2 2020 Aug 13, 2020	BUY	$10.34 - $15.51 $36,200 - $54,300	3,501 Added 82.53%	7,743 $111,000
Q1 2020 May 13, 2020	BUY	$9.11 - $20.05 $38,644 - $85,052	4,242 New	4,242 $54,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.08B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.